Revisiting the role of ABC transporters in multidrug-resistant cancer

Robert W Robey1, Kristen M Pluchino1, Matthew D Hall2

  • 1Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Nature Reviews. Cancer
|April 13, 2018
PubMed

Insights

Investigating ATP-binding cassette (ABC) transporters, like multidrug resistance protein 1 (MDR1), is crucial for overcoming cancer drug resistance. New evidence suggests revisiting these transporters for improved cancer therapy and drug delivery, especially at the blood-brain barrier.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Multidrug resistance (MDR) in cancer, often due to ATP-binding cassette (ABC) transporters, limits therapeutic efficacy.
  • Multidrug resistance protein 1 (MDR1/P-glycoprotein/P-gp), encoded by ABCB1, is a key transporter implicated in chemotherapy resistance.
  • Past efforts to target MDR1 therapeutically were hindered by a lack of adequate tools and understanding.

Purpose of the Study:

  • To re-evaluate the clinical significance of ABC transporters in mediating multidrug resistance in various cancer types.
  • To explore the potential of targeting ABC transporters for enhancing drug delivery, particularly across the blood-brain barrier.
  • To present recent evidence supporting a renewed investigation into ABC transporters as therapeutic targets.

Main Methods:

  • Review and synthesis of recent scientific literature and emerging data on ABC transporters in cancer.
  • Analysis of the role of MDR1, ABCC1 (MRP1), and ABCG2 in drug resistance mechanisms.
  • Examination of the implications of ABC transporter activity at the blood-brain barrier.

Main Results:

  • Evidence suggests that ABC transporters, including MDR1, MRP1, and ABCG2, continue to play a significant role in cancer multidrug resistance.
  • Recent advancements in technology and data provide new opportunities for characterizing and targeting these transporters.
  • The blood-brain barrier presents a critical area where ABC transporters influence drug penetration and efficacy.

Conclusions:

  • It is timely to revisit the investigation of ABC transporters as therapeutic targets in oncology.
  • Targeting ABC transporters could offer novel strategies for improving chemotherapy effectiveness and drug delivery in cancer patients.
  • Further research into ABC transporter function is warranted to overcome drug resistance and enhance treatment outcomes.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.7K
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
3.5K
Nonlinear Pharmacokinetics: Role of Transporters01:27

Nonlinear Pharmacokinetics: Role of Transporters

A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
299
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311
Facilitated Transport01:19

Facilitated Transport

The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
151.0K